MACURE PHARMA ApS — Credit Rating and Financial Key Figures
CVR number: 35234748
Hejrevej 39, 2400 København NV
info@macurepharma.com
tel: 70204107
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 15 148.59 | 24 981.87 | 38 049.17 | 24 158.86 | 39 051.23 |
| Employee benefit expenses | -8 098.58 | -18 271.94 | -15 743.32 | -11 353.89 | -15 044.16 |
| Total depreciation | - 137.24 | - 153.08 | - 137.84 | -1 252.84 | - 438.23 |
| EBIT | 6 912.77 | 6 556.85 | 22 168.01 | 11 552.14 | 23 568.84 |
| Other financial income | 99.75 | 985.18 | 3 268.42 | 4 239.10 | |
| Other financial expenses | - 152.69 | - 172.76 | - 178.03 | -3 454.51 | -16 898.70 |
| Pre-tax profit | 6 760.08 | 6 483.85 | 22 975.15 | 11 366.04 | 10 909.24 |
| Income taxes | -1 502.46 | -1 436.15 | -5 080.61 | -2 575.67 | -2 414.22 |
| Net earnings | 5 257.62 | 5 047.70 | 17 894.55 | 8 790.38 | 8 495.01 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Intangible rights | 1 263.10 | 2 206.60 | 2 571.28 | 4 960.35 | 9 272.20 |
| Intangible assets total | 1 263.10 | 2 206.60 | 2 571.28 | 4 960.35 | 9 272.20 |
| Buildings | 683.90 | ||||
| Tangible assets total | 683.90 | ||||
| Investments total | 151.10 | 146.67 | 167.99 | 169.55 | 1 144.75 |
| Long term receivables total | |||||
| Raw materials and consumables | 2 770.88 | 1 008.76 | 1 549.63 | ||
| Finished products/goods | 23 895.91 | 24 889.15 | 22 219.50 | 23 294.95 | 24 745.46 |
| Advance payments | 214.72 | 238.14 | |||
| Inventories total | 23 895.91 | 24 889.15 | 24 990.38 | 24 518.42 | 26 533.24 |
| Current trade debtors | 23 954.44 | 52 805.50 | 40 220.01 | 28 790.36 | 44 553.67 |
| Current amounts owed by group member comp. | 10 866.99 | ||||
| Prepayments and accrued income | 1 001.00 | 763.55 | 1 845.89 | ||
| Current other receivables | 1 558.54 | 28 636.01 | 67 616.71 | 101 539.70 | |
| Current deferred tax assets | 252.09 | 186.39 | 486.17 | 280.30 | 17.13 |
| Short term receivables total | 25 765.07 | 63 858.88 | 70 343.20 | 97 450.92 | 147 956.39 |
| Cash and bank deposits | 6 476.43 | 9 383.60 | 18 487.56 | 43 174.08 | 16 919.65 |
| Cash and cash equivalents | 6 476.43 | 9 383.60 | 18 487.56 | 43 174.08 | 16 919.65 |
| Balance sheet total (assets) | 57 551.60 | 100 484.90 | 116 560.40 | 170 273.32 | 202 510.14 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Share capital | 80.00 | 80.00 | 80.00 | 80.00 | 80.00 |
| Shares repurchased | 5 000.00 | 5 000.00 | 18 000.00 | 7 700.00 | 8 000.00 |
| Retained earnings | 114.39 | 372.02 | -12 580.29 | -2 385.74 | -1 595.37 |
| Profit of the financial year | 5 257.62 | 5 047.70 | 17 894.55 | 8 790.38 | 8 495.01 |
| Shareholders equity total | 10 452.01 | 10 499.71 | 23 394.26 | 14 184.63 | 14 979.65 |
| Non-current liabilities total | |||||
| Current loans from credit institutions | 96.93 | 169.28 | |||
| Advances received | 464.78 | 63.30 | 103.69 | ||
| Current trade creditors | 12 154.81 | 27 639.82 | 23 540.23 | 21 298.99 | 27 692.31 |
| Current owed to participating | 20.70 | 21 004.33 | 40.82 | 52.19 | 98.82 |
| Current owed to group member | 31 283.02 | 22 216.85 | 62 641.67 | 131 135.00 | 151 495.69 |
| Short-term deferred tax liabilities | 1 775.59 | 1 370.45 | 5 380.39 | 2 369.80 | 2 151.06 |
| Other non-interest bearing current liabilities | 1 865.48 | 17 753.73 | 1 098.26 | 1 072.48 | 5 819.65 |
| Current liabilities total | 47 099.59 | 89 985.18 | 93 166.15 | 156 088.69 | 187 530.49 |
| Balance sheet total (liabilities) | 57 551.60 | 100 484.90 | 116 560.40 | 170 273.32 | 202 510.14 |
CreditReports API
- Company information
- Financial data
- Credit risk data
- All 400,000+ Danish companies
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.